Cancer Frontiers (Audio)
Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
04 Aug 2025
Dr. Ivan de Kouchkovsky explains how radioligand therapy delivers targeted radiation to prostate cancer cells using a radioactive isotope attached to a molecule that binds to PSMA, a protein commonly expressed in these tumors. He reviews key clinical trials showing how the therapy improves survival and quality of life for men with metastatic castration-resistant prostate cancer, both after and before chemotherapy. The FDA now approves this approach for patients who have progressed on hormone therapy, even if they haven’t yet received chemotherapy. De Kouchkovsky also highlights efforts to enhance effectiveness by combining therapies, increasing radiation dose, and targeting resistant or PSMA-negative cells. Diagnostic imaging plays a critical role in selecting patients most likely to benefit from treatment. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40810]
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE
01 Jan 1970
El Partidazo de COPE
12:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
#158 - Szilágyi Tamás: A húszas éveid arra valók, hogy legalább egyszer becsődölj
21 Dec 2025
Mindenségit!
Tödliche Ernte
21 Dec 2025
Schattenakte - Der Fall der Woche
Origines de Stars : Shai Gilgeous Alexander ! (Calendrier Avent #21)
21 Dec 2025
Le Basket Lab (NBA Podcast)
The BEST XI in the 2025 West Indies Championship
21 Dec 2025
Caribbean Cricket Podcast